Opinion - Page 2

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. I’d

A lawsuit targeting a landmark disability law has received new life after nine states filed an update that seeks to undercut federal mandates that people with disabilities receive care in their communities.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. After O. Rose Broderick reported that some members of a federal autism

NEW YORK — U.S. life expectancy rose to 79 years in 2024 — the highest mark in American history. It’s the result of not only the dissipation of the Covid-19 pandemic, but also

WASHINGTON — The Trump administration’s abrupt overhaul of the federal vaccine schedule sent shockwaves through American health care earlier this month. But the biggest impacts are likely to come in the weeks

It was cast as a lifesaving medication, a “best-in-class” overdose antidote built specifically for the fentanyl era. It was far more powerful than Narcan, the nasal spray it was designed to supplant.

The Department of Health and Human Services on Wednesday announced the appointment of 21 new members to a federal committee that advises health secretary Robert F. Kennedy Jr. on autism. Many of

WASHINGTON — The government proposed new rules for the nation’s transplant system Wednesday that aim to increase use of less-than-perfect organs and set additional safety standards for donor groups. The Centers for Medicare and Medicaid Services

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. For a change of pace, I’d recommend this delightful Letter of Recommendation. “It

Nick Leschly, the CEO who became synonymous with the curative promise and complicated reality of gene therapy, is back with a new company. The startup, Altido Therapeutics, is trying to commercialize a